Home » 幹細胞新聞 » 環境帶來的疾病或傷害 » Stem cell-based heart-attack therapy approved for clinical trials

Marking a first for the California Institute for Regenerative Medicine, the FDA has given the go-ahead for clinical trials on a stem-cell based approach to repairing damage caused by heart attack. CIRM provided funding to the Cedars-Sinai Heart …
[Read more]

Comments are closed.

免費訂閱最新資訊

只需輸入閣下之電郵地址,我們便會向定時你發送本站最新新聞及相關資訊,費用全免。

聯絡我們

Name*

Email*

Tel

Message*

captcha

*require